NIPH Clinical Trials Search

Basic Information

Recruitment status
Health condition(s) or Problem(s) studied	Prevention of influenza
Date of first enrollment	20/10/2016
Target sample size	600
Countries of recruitment
Study type	Interventional
Intervention(s)	investigational material(s) Generic name etc : BK1304 INN of investigational material : Therapeutic category code : 631 Vaccines Dosage and Administration for Investigational material : 2 doses of intranasal administration

Outcome(s)

Primary Outcome	Efficacy
Secondary Outcome	Immunogenicity, Safety

Key inclusion & exclusion criteria

Age minimum	>= 20age old
Age maximum	<= 64age old
Gender	Both
Include criteria	Written informed consent is obtained from subject
Exclude criteria